Which hyperthyroid patient is the best candidate for radioactive iodine therapy?

Prepare effectively for the Physician Assistant Clinical Knowledge Rating and Assessment Tool (PACKRAT) 1 Exam with comprehensive resources, flashcards, and detailed explanations. Ace your test with ease!

Multiple Choice

Which hyperthyroid patient is the best candidate for radioactive iodine therapy?

Explanation:
Radioactive iodine therapy is a definitive, non-surgical approach that's especially suited for older patients with Graves' disease. In those over around 65, the risks of thyroid surgery and general anesthesia are higher, making a single, outpatient treatment that destroys overactive thyroid tissue very appealing. Most patients end up hypothyroid after treatment, but that outcome is easy to manage with lifelong thyroid hormone replacement. Subacute thyroiditis isn’t a good candidate because the hyperthyroidism comes from leaked preformed hormone and the gland’s uptake of iodine is low, so RAI won’t correct the problem. A pregnant patient is a contraindication due to fetal radiation exposure. A toxic adenoma can respond to RAI, but in an older patient with Graves' disease, the elderly patient’s overall treatment risk profile makes RAI the preferable option.

Radioactive iodine therapy is a definitive, non-surgical approach that's especially suited for older patients with Graves' disease. In those over around 65, the risks of thyroid surgery and general anesthesia are higher, making a single, outpatient treatment that destroys overactive thyroid tissue very appealing. Most patients end up hypothyroid after treatment, but that outcome is easy to manage with lifelong thyroid hormone replacement.

Subacute thyroiditis isn’t a good candidate because the hyperthyroidism comes from leaked preformed hormone and the gland’s uptake of iodine is low, so RAI won’t correct the problem. A pregnant patient is a contraindication due to fetal radiation exposure. A toxic adenoma can respond to RAI, but in an older patient with Graves' disease, the elderly patient’s overall treatment risk profile makes RAI the preferable option.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy